LightMix® Digital Assays 

LightMix® Digital Assays, developed by TIB Molbiol in collaboration with Roche, provide an advanced solution for the precise detection and quantification of specific genetic mutations associated with various cancers. By utilizing digital PCR technology, these assays partition samples into thousands of individual reactions, enabling absolute quantification with unparalleled sensitivity and specificity. This approach is particularly advantageous for identifying low-abundance mutations in complex samples, facilitating early detection and informed therapeutic decisions.​

The LightMix® Digital Assay portfolio includes tests for critical oncogenic mutations such as BRAF V600E, EGFR T790M, EGFR Ex19del, KRAS G12D, and PIK3CA E545K, among others. Optimized for seamless integration with Roche's digital PCR platforms, these assays offer rapid turnaround times and user-friendly workflows, making them an invaluable tool for laboratories aiming to enhance their molecular diagnostics capabilities in oncology.

Please find the assay menu here and contacts to your local Roche distributor here below:

German customers please click here and look for "Molekulare Diagnostik"

International customers please click here and contact your local Roche distributor directly.

​

​